Showing results (131-140 of 442) with videos related to
Sort By:
Pageof 45
The American Journal of Gastroenterology|July 1, 2010
The inflammatory bowel diseases and ambient air pollution: a novel associationGilaad G Kaplan, James Hubbard, Joshua Korzenik, et al.Journal of Crohn'S & Colitis|March 17, 2018
Pregnant Women with Inflammatory Bowel Disease Are at Increased Risk of Vitamin D Insufficiency: A Cross-Sectional StudySangmin Lee, Amy Metcalfe, Maitreyi Raman, et al.Journal of Crohn'S & Colitis|July 5, 2020
Smoking May Reduce the Effectiveness of Anti-TNF Therapies to Induce Clinical Response and Remission in Crohn's Disease: A Systematic Review and Meta-analysisSangmin Lee, M Ellen Kuenzig, Amanda Ricciuto, et al.Advances in Therapy|November 22, 2019
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated AnalysisGerd R Burmester, Kenneth B Gordon, James T Rosenbaum, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2008
Anti-aging therapy with human growth hormone associated with metastatic colon cancer in a patient with Crohn's colitisGil Y Melmed, Shane M Devlin, George Vlotides, et al.Inflammatory Bowel Diseases|November 25, 2011
Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritisKhaled Al-Jarallah, Diaa Shehab, Rajaa Al-Attiyah, et al.Nature Reviews. Disease Primers|May 21, 2020
Author Correction: Crohn's diseaseGiulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, et al.Nature Reviews. Disease Primers|June 21, 2020
Author Correction: Crohn's diseaseGiulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, et al.Gastroenterology|February 14, 2006
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trialStephen B Hanauer, William J Sandborn, Paul Rutgeerts, et al.Inflammatory Bowel Diseases|November 24, 2015
Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized TrialJennifer deBruyn, Kevin Fonseca, Subrata Ghosh, et al.Pageof 45